IBIO INC (IBIO)

US4510336096 - Common Stock

0.752  -0.04 (-4.81%)

After market: 0.76 +0.01 (+1.06%)

News Image
19 days ago - iBio, Inc.

iBio to Participate in the JMP Securities Life Sciences Conference

BRYAN, Texas and SAN DIEGO, May 09, 2023 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO) (“iBio” or the “Company”), an AI-driven innovator of precision...

News Image
2 months ago - iBio, Inc.

iBio Discovers New Panel of CD3 T-Cell Binding Antibodies Using its Patented AI Epitope Steering Platform

BRYAN, Texas, April 04, 2023 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO) (“iBio” or the “Company”), an AI-driven innovator of precision antibody...

News Image
2 months ago - iBio, Inc.

iBio Advances Anti-CCR8 Antibody Program to Preclinical In Vivo Testing

– Immuno-oncology candidate discovered using iBio’s AI epitope steering platform – – Expands Treg depletion franchise beyond IBIO-101 – BRYAN, Texas,...

News Image
2 months ago - InvestorPlace

7 Stocks to Sell as Banks Melt Down

Although the internet encourages you to buy the red ink, sometimes you should consider stocks to sell as just that.

News Image
3 months ago - InvestorPlace

Why Is Ambrx Biopharma (AMAM) Stock Down 15% Today?

Ambrx Biopharma (AMAM) stock is falling on Friday but it's not due to any negative news released by the medical company today.

News Image
3 months ago - InvestorPlace

Why Is VolitionRX (VNRX) Stock Down 17% Today?

VolitionRX (VNRX) stock is taking a beating on Friday after the company revealed a proposed public offering for its shares.

News Image
3 months ago - InvestorPlace

Why Is Nogin (NOGN) Stock Up 25% Today

Nogin (NOGN) stock is taking off on Friday with heavy trading volume after announcing an agreement with Seychelles Imports.

News Image
3 months ago - InvestorPlace

Why Is iBio (IBIO) Stock Up 124% Today?

Ibio (IBIO) stock is rocketing higher on Friday after the biopharmaceutical company announced a new immune-oncology program.

News Image
3 months ago - InvestorPlace

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

We're starting off the final trading day of the week with a look at the biggest pre-market stock movers worth watching on Friday!

News Image
3 months ago - Seeking Alpha

iBio (NYSE:IBIO) announces new immuno-oncology target program

iBio (IBIO) on Thursday said it would target MUC16, a protein expressed in several types of cancers, for its latest immuno-oncology program. Read more here.

News Image
3 months ago - iBio, Inc.

iBio Announces MUC16 as its Latest Immune-Oncology Target Program

- Company has directed antibodies against a specific region of MUC16 - - Potentially offers a differentiated and effective tool in the fight against...

News Image
3 months ago - InvestorPlace

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

We're starting off another day of trading with a breakdown of the biggest pre-market stock movers for trader need to kno about Wednesday!

News Image
6 months ago - iBio, Inc.

iBio Announces Closing of $3.5 Million Underwritten Public Offering

BRYAN, Texas, Dec. 09, 2022 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA: IBIO) (“iBio” or the “Company”), an AI-driven innovator of precision antibody...

News Image
6 months ago - InvestorPlace

7 Penny Stocks to Sell Before They Plunge in 2023

These penny stocks to sell have been incredibly volatile this year and should be discarded from your portfolios heading into 2023.

News Image
6 months ago - InvestorPlace

25 Penny Stocks to Sell Before They Die

Wondering which small-cap companies you should offload before 2023? Here are the top picks for penny stocks to sell while you still can.

News Image
6 months ago - InvestorPlace

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

It's time for another dive into the biggest pre-market stock movers as we check out the latest news traders need to know about on Wednesday!

News Image
6 months ago - iBio, Inc.

iBio Announces Pricing of $3.5 Million Underwritten Public Offering

BRYAN, Texas, Dec. 06, 2022 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA: IBIO) (“iBio” or the “Company”), an AI-driven innovator of precision antibody...

News Image
6 months ago - iBio, Inc.

iBio Announces Proposed Underwritten Public Offering

BRYAN, Texas, Dec. 06, 2022 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA: IBIO) (“iBio” or the “Company”), an AI-driven innovator of precision antibody...

News Image
6 months ago - iBio, Inc.

iBio® to Showcase the RubrYc® Discovery Engine During Poster Presentations at Antibody Engineering & Therapeutics Conference 2022

BRYAN, Texas, Dec. 05, 2022 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO) (“iBio” or the “Company”), an AI-driven innovator of precision antibody...

News Image
6 months ago - Seeking Alpha

iBio's CEO, Thomas F. Isett departs (NYSE:IBIO)

iBio (IBIO) announced that the Board of Directors and Thomas F. Isett, company’s CEO, have agreed that Mr

News Image
6 months ago - iBio, Inc.

iBio Announces CEO Departure

BRYAN, Texas, Dec. 02, 2022 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO) (“iBio” or the “Company”), an AI-driven innovator of precision antibody...